Home/Filings/4/0000950170-24-129381
4//SEC Filing

Quirk Gerald E 4

Accession 0000950170-24-129381

CIK 0001556263other

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 5:00 PM ET

Size

5.0 KB

Accession

0000950170-24-129381

Insider Transaction Report

Form 4
Period: 2024-11-19
Quirk Gerald E
Chief Legal Officer
Transactions
  • Sale

    Common Stock

    2024-11-19$0.22/sh46,657$10,3210 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.2211 to $0.2249, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.

Documents

1 file

Issuer

Syros Pharmaceuticals, Inc.

CIK 0001556263

Entity typeother

Related Parties

1
  • filerCIK 0001479603

Filing Metadata

Form type
4
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 5:00 PM ET
Size
5.0 KB